Abordaje integral de las personas con diabetes tipo 2. Área de Conocimiento de Diabetes de la Sociedad Española de Endocrinología y Nutrición-Reference-Cited by-同舟云学术

Abordaje integral de las personas con diabetes tipo 2. Área de Conocimiento de Diabetes de la Sociedad Española de Endocrinología y Nutrición

Published:2023-03 Issue: Volume:70 Page:95-102
ISSN:2530-0164
Container-title:Endocrinología, Diabetes y Nutrición
language:es
Short-container-title:Endocrinología, Diabetes y Nutrición

Author:

Reyes-García Rebeca,Moreno-Pérez Óscar,Bellido Virginia,Botana-López Manuel,Duran Rodríguez-Hervada Alejandra,Fernández-García Diego,Fernández-García José Carlos,Gargallo-Fernández Manuel,González-Clemente Jose Miguel,Jódar-Gimeno Esteban,López de la Torre Casares Martín,López-Fernández Judith,Marco Martínez Amparo,Mezquita-Raya Pedro,Rozas-Moreno Pedro,Tejera-Pérez Cristina,Escalada-San Martín Javier

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference10 articles.

1. Introduction: Standards of Medical Care in Diabetes—2022;Diabetes Care,2022

2. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range;Battelino;Diabetes Care.,2019

3. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN);Gargallo-Fernández;Endocrinol Diabetes Nutr (Engl Ed).,2021

4. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Suppl 1):S60-S82. https://doi.org/10.2337/dc22-S005.

5. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain;Advances in Therapy;2024-07-22

2. Current barriers to initiating insulin therapy in individuals with type 2 diabetes;Frontiers in Endocrinology;2024-03-14